Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Vistagen Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 112 | 93 | −19 |
| Shares | 138.8M | 56.5M | −82.3M (−59.3%) |
| Value | $122.1M | $9.13M | −$113.0M (−92.5%) |
New holders (17)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 234,400 | $36.0K | 0.00% |
| Virtu Financial LLC | 230,742 | $35.0K | 0.00% |
| Acadian Asset Management LLC | 186,416 | $28.0K | 0.00% |
| TKG Advisors, LLC | 134,860 | $21.0K | 0.02% |
| Advisors Capital Management, LLC | 65,000 | $10.0K | 0.00% |
| Jane Street Group, LLC | 68,156 | $10.0K | 0.00% |
| Two Sigma Securities, LLC | 58,096 | $9.00K | 0.00% |
| Neuberger Berman Group LLC | 56,617 | $9.00K | 0.00% |
| Balyasny Asset Management LLC | 34,596 | $5.00K | 0.00% |
| Ameriprise Financial Inc | 21,775 | $3.00K | 0.00% |
| MML Investors Services, LLC | 15,000 | $2.00K | 0.00% |
| Mariner, LLC | 12,841 | $2.00K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,531 | $2.00K | 0.00% |
| Sawtooth Solutions, LLC | 14,562 | $2.00K | 0.00% |
| Boyd Wealth Management, LLC | 12,180 | $2.00K | 0.00% |
| Twin Lakes Capital Management, LLC | 12,500 | $2.00K | 0.00% |
| Clear Street Markets LLC | 536 | $0 | 0.00% |
Sold out (36)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.